|Bid||9.03 x 0|
|Ask||9.04 x 0|
|Day's Range||8.91 - 9.29|
|52 Week Range||6.55 - 20.08|
|Beta (5Y Monthly)||1.83|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 04, 2021 - Aug 09, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||7.58|
ARRY, CRON, ESTC, LEVL and TME have been added to the Zacks Rank #5 (Strong Sell) List on August 4, 2021.
According to New Frontier Data, legal weed sales in the U.S. are expected to grow by an annual average of 21%, ultimately hitting north of $41 billion by mid-decade. While this sales growth will undoubtedly make some cannabis investors rich, we also know that not every marijuana stock can be a winner. The following trio of pot stocks stand out for all the wrong reasons and should be avoided like the plague in August.
Canadian marijuana stocks have fallen from their February highs. But one player in the industry got a lot bigger after a merger deal.